Intellia Therapeutics
NTLA
141 hedge funds and large institutions have $430M invested in Intellia Therapeutics in 2018 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 36 closing their positions.
54% more call options, than puts
Call options by funds: $2.21M | Put options by funds: $1.43M
5.23% more ownership
Funds ownership: 67.37% → 72.6% (+5.2%)
5% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 40
10% less funds holding
Funds holding: 157 → 141 (-16)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
42% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 36
48% less capital invested
Capital invested by funds: $833M → $430M (-$403M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OTPPB
Ontario Teachers' Pension Plan Board
Toronto,
Ontario, Canada
|
+$30.9M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$19.5M |
| 3 |
Morgan Stanley
New York
|
+$4.87M |
| 4 |
State Street
Boston,
Massachusetts
|
+$4.6M |
| 5 |
Renaissance Technologies
New York
|
+$4.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$15.7M |
| 2 |
O
OrbiMed
New York
|
-$6.82M |
| 3 |
GAM
Greenwoods Asset Management
Grand Cayman,
Cayman Islands
|
-$4.99M |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$4.07M |
| 5 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
-$3.63M |
NTLA Hedge Fund Activity: Q4 2018 in Review
141 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Intellia Therapeutics (NTLA) for Q4 2018, worth a combined $430M — down 48% from $833M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of NTLA and 21 opened new positions — a net loss of 15 holders — while 40 trimmed existing stakes and 42 added.
The largest buyer was Ontario Teachers' Pension Plan Board, opening a new position worth an estimated $30.9M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $15.7M sold.
- 141 institutional investors held Intellia Therapeutics (NTLA) as of Q4 2018, down from 157 in Q3 2018.
- Funds reported $430M of Intellia Therapeutics stock for Q4 2018, down 48% quarter-over-quarter.
- 21 funds opened new Intellia Therapeutics positions in Q4 2018 and 36 closed out, a net change of -15 holders.
- The largest Intellia Therapeutics buyer in Q4 2018 was Ontario Teachers' Pension Plan Board, an estimated $30.9M added.
- The largest Intellia Therapeutics seller in Q4 2018 was Farallon Capital Management, an estimated $15.7M sold.
Based on aggregated 13F filings for Q4 2018.